Search

for
Search:

GlossaryBiologics (Biopharmaceuticals)

medications derived from living organisms to treat various diseases

Biologics, also known as biological drugs or biopharmaceuticals, are a category of medications derived from living organisms, such as cells, tissues, or proteins. Unlike traditional chemical drugs, biologics are typically large, complex molecules that target specific components of the immune system or cellular processes, making them effective for treating conditions like autoimmune diseases, cancers, and certain types of alopecia.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 269 results

research Technology Development of Herbal Remedies for Androgenic Alopecia External Application

1 citations, October 2015 in “The Pharma Innovation Journal”

The best way to make a topical treatment for hair loss is to mix Saw Palmetto extract with 48% ethanol at the end of making the lotion.

research Effect of Prostaglandin D2 on Hair Follicle Growth and Its Impact on Hair Follicle Stem/Progenitor Cells

1 citations, April 2016 in “Journal of Investigative Dermatology”

Blocking Prostaglandin D₂ may help treat hair loss.

research Oncostatin M Is Upstream of JAK-STAT Signaling During the Murine Hair Cycle

April 2016 in “Journal of Investigative Dermatology”

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

research 702 dsRNA Induces Ectopic KRT9 Expression via WNT/β-Catenin-Mediated Signaling

April 2016 in “Journal of Investigative Dermatology”

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

research Signaling Networks Between Stem Cell Precursors, Transit Amplifying Progenitors, and Their Niche in Developing Hair Follicles

April 2016 in “Journal of Investigative Dermatology”

Blocking Prostaglandin D₂ (PGD₂) could help treat hair loss.

View more "biopharmaceuticals" in research →

Community Join

3 / 3 results

community HMI-115: What We Know So Far. HMI-115 (also known as BAY1158061) is a new pharmaceutical drug developed by a biopharmaceutical company called Bioinvent and licensed by Bayer

in Research/Science 51 upvotes 10 months ago

HMI-115 is a new drug developed by Bioinvent and licensed by Bayer, with mixed opinions on its potential effectiveness. Some users are skeptical and prefer proven treatments like Minoxidil, finasteride, and RU58841.

community Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments

in Treatment 39 upvotes 6 months ago

AMP-303, a new injectable treatment for androgenetic alopecia, showed promising results in increasing hair count and density with minimal side effects. The treatment demonstrated significant hair regrowth and durability, offering new hope for those with hair loss.

community Phase II for Technoderma Therepeutic's TDM-105795 set to begin in April tentatively

in Research/Science 41 upvotes 2 years ago

Phase II for TDM-105795 for Androgenic Alopecia is set to begin in April 2023. The study aims to evaluate the efficacy and safety of TDM-105795 in male subjects.